JPRN-UMIN000006330已完成3 期
tissue type plasminogen activator(t-PA) and Edaravon combination therapy study - YAMATO study
eurology, Nippon Medical School0 个研究点目标入组 200 人开始时间: 2011年12月10日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patients with large infarcts on initial diffusion-weighted imaging (DWI) were excluded, using a DWI Alberta Stroke Programme Early computed tomography score (DWI-ASPECTS) of 4 and under to define large infarcts. (2)Patients with internal carotid artery occlusion. (3)Patients diagniosed as having bilateral symptomatic MCA occlusion. (4)Patients with serum concentration of creatinine over 1.5mg/dl (5)Patients who cannot be exmined using Magnetic resonance imaging. (6)Patients who is and is suspected to be pregnant (7)Patients with contraindication to the use of edaravone and to the Japanese guidelin of the t-PA infusion.
研究者
相似试验
招募中
3 期
The role of anticoagulant and thrombolitic in treatment of COVID patientsCOVID 19.COVID-19, virus identifiedU07.1IRCT20200515047456N1Tabriz University of Medical Sciences15
已完成
不适用
Recombinant tissue Plasminogen Activator administration by retinal branch vein route for Central Retinal Vein Occlusion: a randomised conventional therapy controlled trialCentral Retinal Vein Occlusion (CRVO)Eye DiseasesISRCTN58543190Oogziekenhuis Rotterdam (OZR) (The Netherlands)48
尚未招募
不适用
Tissue Plasminogen Activator levels in Diabetic footCTRI/2020/07/026277AIIMS Bhubaneswar
进行中（未招募）
1 期
A clinical trial of a clot dissolving drug and gas, injected into the eye, to treat bleeding associated with wet age-related macular degeneratioSub-macular haemorrhage secondary to wet macular degenerationMedDRA version: 16.0Level: PTClassification code 10064930Term: Age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersMedDRA version: 16.0Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disordersEUCTR2012-004078-24-GBKing's College London
已完成
2 期
Effect of treatment with tissue plasminogen activator in improving clinical status of patients with acute ischemic strokeIRCT201709049014N182Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences40